Imaging the Pancreas With MRI in Type 1 Diabetes
Studies pancreas MRI scans in people with type 1 diabetes and other diabetes types.
Plain-language title generated from the registry record
Registry title: Multicenter Assessment of the Pancreas in Type 1 Diabetes
Key facts
- Where
- Aurora, Austin, Chicago, and Nashville, United StatesSee the 4 sites
Where in United States
- University of Colorado, Barbara Davis CenterAurora, United StatesNo longer taking part
- University of Texas at Austin, Dell Medical SchoolAustin, United StatesNo longer taking part
- University of Chicago, Kovler Diabetes CenterChicago, United StatesNo longer taking part
- Vanderbilt University Medical CenterNashville, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vanderbilt University Medical Center
- Trial code
- NCT03585153
- Record updated
- 23 October 2026
- Original description
The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.Read full original descriptionShow less
Multicenter Assessment of the Pancreas in Type 1 Diabetes
The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.
Inclusion: Subjects at least 8 years of age; Subjects with T1D must be imaged within 100 days of their date of diagnosis; Subjects must be able to read and provide assent/informed written consent.
Exclusion: Subjects with pancreatitis, cystic fibrosis, pancreatic adenocarcinoma, or neuroendocrine tumors; Subjects who have any type of bioimplant activated by mechanical, electronic, or magnetic means because such devices may be displaced or malfunction; Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced; Subjects who are pregnant or breast-feeding. Urine pregnancy test will be performed on women of child bearing potential who are not practicing appropriate contraception measures or menstruating; Subjects who exhibit significant anxiety and/or claustrophobia; Subjects incapable of giving assent/informed written consent; For controls: subjects who have first degree relatives with T1D.